NCT02121327

The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke

Disease Management Program (DMP) Stroke Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 321 (actual)
• Sponsor: Hiroshima University · Academic / Other
• Sex: All
• Age: 40 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

It has been reported that stroke is the first cause of becoming bedridden, and its cumulative recurrence rate in 5 years is approximately 35%. There is a high probability that patients reduce or discontinue medications by self-determination, leading to a high risk of stroke recurrence in these patients. Comprehensive and long-term patient educations ameliorating their self-management are important making patients possible to be managed according to the guidelines for their risk factors. Using disease management programs created for each of risk factors according to clinical practice guidelines, the influence of those programs were evaluated for the prevention of stroke recurrence in this Disease Management Program Stroke Trial.

Conditions

• Ischemic Stroke

Interventions

Type	Name	Description
OTHER	disease management	disease management program include self management education
OTHER	usual care	usual care group receive regular outpatient treatment

Timeline

• Start date: 2010-09-01
• Primary completion: 2017-02-01
• Completion: 2017-12-01
• First posted: 2014-04-23
• Last updated: 2018-02-22

Locations

1 site across 1 country: Japan